Page last updated: 2024-11-04

sulpiride and Chronic Fatigue and Immune Dysfunction Syndrome

sulpiride has been researched along with Chronic Fatigue and Immune Dysfunction Syndrome in 1 studies

Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pardini, M1
Guida, S1
Primavera, A1
Krueger, F1
Cocito, L1
Gialloreti, LE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Shanghai University of Traditional Chinese Medicine[NCT03496961]135 participants (Anticipated)Interventional2018-12-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for sulpiride and Chronic Fatigue and Immune Dysfunction Syndrome

ArticleYear
Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2011, Volume: 21, Issue:3

    Topics: Amisulpride; Dopamine Antagonists; Fatigue Syndrome, Chronic; Female; Fluoxetine; Humans; Male; Pilo

2011